News

Published on 10 May 2024 on Insider Monkey via Yahoo Finance

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript


Article preview image

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript May 9, 2024

Catalyst Pharmaceuticals, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Greetings, and welcome to the Catalyst Pharmaceuticals' First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mike Kalb, Chief Financial Officer. Thank you, sir. You may begin.

NASDAQ.CPRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

In the same year, the company also acquired North American commercial and developmental rights to...

Zacks · via Yahoo Finance 9 Jan 2025

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

On Wednesday, Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) entered into a settlement agreement wit...

Benzinga · via Yahoo Finance 9 Jan 2025

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Catalyst Pharmaceutical (CPRX) Coral Gables, FL-based Catalyst Pharmaceuticals, Inc. is a...

Zacks · via Yahoo Finance 7 Jan 2025

Is Catalysts Pharmaceuticals, Inc. (CPRX) the Best Performing Biotech Stock in...

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we...

Insider Monkey · via Yahoo Finance 24 Dec 2024

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong...

Catalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up ...

Simply Wall St. · via Yahoo Finance 4 Dec 2024

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong...

Catalyst Pharmaceuticals Inc (CPRX) reports a 25.3% increase in total revenue and updates its...

GuruFocus.com · via Yahoo Finance 11 Nov 2024

Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Report Preview: What To...

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) is set to release its Q3 2024 earnings on Nov 7, 2024....

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating &...

On August 20, 2024, Steve Miller, the Chief Operating & Scientific Officer of Catalyst Pharmaceut...

GuruFocus.com · via Yahoo Finance 20 Aug 2024

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong...

Most readers would already know that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased by 4...

Simply Wall St. · via Yahoo Finance 19 Jun 2024

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Catalys...

Insider Monkey via Yahoo Finance 10 May 2024